American Biotech Labs(R) Garners 2009 Utah Best of State Award



    
    For the second time in three years, the Best of State Program's
    independent judges have recognized American Biotech Labs(R) as Utah's top
    company in the Medical Innovation category
    

    SALT LAKE CITY, UT, June 4 /CNW/ - American Biotech Labs, LLC (ABL),
developer of a new class of products based on the company's patented
nano-catalytic SilverSol Technology(R), today announced that the company has
won the 2009 Utah Best of State award in the category of Medical Innovation.
It is the company's second Best of State award in the past three years.
    "We are honored that the Best of State judges have chosen to honor ABL
with a 2009 Best of State award in the Medical Innovation category," said Dr.
William Moeller, a managing director at American Biotech Labs. "This
recognition highlights the reality that we are in the midst of a period of
tremendous growth, as an increasing number of people throughout the world are
beginning to recognize the benefits of ABL's uniquely effective patented
silver products."
    ABL received its Best of State award May 30 at the 2009 Best of State
Awards Gala, a formal dinner event in the Salt Palace Convention Center
Ballroom in Salt Lake City. The Best of State program, now in its seventh
year, is a multi-faceted recognition program created by award-winning writer,
producer and director Mark Layton and 20-year production and management
executive Dana Layton to highlight excellence in business, government,
education, philanthropy and the arts in Utah.
    Winners for the annual Best of State event are chosen for their
excellence in a wide variety of endeavors. Candidates are judged based on
three criteria: achievement within their field of endeavor (50 percent);
innovation or creativity in approach, techniques, methods or processes (30
percent); and contribution to improving the quality of life in Utah (20
percent). Best of State nominees are evaluated by a panel of more than 100
independent judges.
    ABL products have received multiple U.S. and international patents and
government approvals, including EPA and FDA approval. Most recently, in April
2009, the U.S. Food and Drug Administration (FDA) granted ABL's ASAP Wound
Dressing Gel with 510(k) medical device approval "for the topical management
of minor cuts, lacerations, abrasions, 1st and 2nd degree burns, and skin
irritations." The product utilizes ABL's innovative SilverSol Technology,
which has garnered multiple patents in the U.S. and countries throughout the
world, including a broad-spectrum use patent for combating many of the world's
most destructive pathogens, including malaria, tuberculosis, MRSA and HIV.
    ABL has performed extensive anti-microbial studies against bacteria,
yeast, fungus and other pathogens. Information about some of these studies is
available at the research section of the ABL Website,
www.americanbiotechlabs.com/researchprotected/researchmenu.html.

    About American Biotech Labs

    American Biotech Labs (ABL; www.americanbiotechlabs.com), founded in
1998, utilizes patented processes and SilverSol Technology(R) to create
singularly powerful and effective nano-catalytic silver products. In extensive
testing performed by a variety of respected laboratories and researchers,
ABL's silver hydrosol has consistently demonstrated the ability, without any
known toxic side effects, to destroy a wide range of bacteria, viruses, yeast,
and molds. ABL products have been approved by the Environmental Protection
Agency (EPA) as a disinfectant for dental water lines, and as a surface
disinfectant for bacteria, yeast and mold in hospital, residential, commercial
and industrial settings; and by the U.S. Food and Drug Administration (FDA)
for wound management. The company's products have been the subject of multiple
peer-reviewed articles in professional journals, and are sold worldwide at
health food stores and by medical professionals under the Silver Biotics(R)
and ASAP Solution(R) brands, and through a variety of private labels.





For further information:

For further information: Press Contact: Kimball Thomson, Next Phase
Communications (for American Biotech Labs), kthomson@npcomm.com, (801)
918-3637

Organization Profile

American Biotech Labs, LLC

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890